All In Biotech

Free tool

FAERS Monitor: Brevital Sodium

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011559 or its brand name (Brevital Sodium, Methohexital Sodium). Reports on generic versions are filed under their own applications.

Reports

126

Serious

35

28% of reports

Hospitalization

13

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective66
  • product quality issue25
  • off label use8
  • drug effect decreased7
  • vomiting7
  • nausea6
  • drug effect less than expected5
  • maternal exposure during pregnancy5
  • unwanted awareness during anaesthesia5
  • hypotension4
  • airway complication of anaesthesia3
  • blood pressure decreased3
  • bradycardia3
  • dyspnoea3
  • ventricular extrasystoles3

Reports by year received

View as table
YearReports
20051
20063
20084
20094
20107
20111
20125
20131
20141
201511
201613
20172
20182
201923
202015
20217
20229
20233
20243
20257
20264

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,033 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
unwanted awareness during anaesthesiaSignal52586.61088.210,307
airway complication of anaesthesiaSignal31928.0626.23,966
drug effect less than expectedSignal556.323.9219
ventricular extrasystolesSignal348.215.896
product quality issueSignal2530.721.6694
drug effect decreasedSignal721.710.6119
bradycardiaSignal39.43.115
maternal exposure during pregnancySignal59.44.030
drug ineffectiveSignal668.47.1448
blood pressure decreasedSignal37.52.511
hypotensionSignal43.31.34
vomitingSignal72.51.25
off label use81.50.81
nausea61.30.60
dyspnoea30.90.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.